0001437749-14-000043.txt : 20140102 0001437749-14-000043.hdr.sgml : 20140101 20140102160242 ACCESSION NUMBER: 0001437749-14-000043 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140102 FILED AS OF DATE: 20140102 DATE AS OF CHANGE: 20140102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TearLab Corp CENTRAL INDEX KEY: 0001299139 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 593434771 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9980 HUENNEKENS ST. STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-794-1400 MAIL ADDRESS: STREET 1: 9980 HUENNEKENS ST. STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: OccuLogix, Inc. DATE OF NAME CHANGE: 20040730 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Karpecki Paul CENTRAL INDEX KEY: 0001487348 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51030 FILM NUMBER: 14501805 MAIL ADDRESS: STREET 1: 11025 ROSELLE STREET STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 rdgdoc.xml PRIMARY DOCUMENT X0306 4 2014-01-02 0001299139 TearLab Corp TEAR 0001487348 Karpecki Paul 9980 HUENNEKENS ST., STE 100 SAN DIEGO CA 92121 1 Common Stock 2014-01-02 4 M 0 3376 3.12 A 6876 D Common Stock 2014-01-02 4 M 0 548 2.59 A 7424 D Common Stock 2014-01-02 4 M 0 1076 2.11 A 8500 D Common Stock 2014-01-02 4 S 0 5000 9.4687 D 3500 D Stock Option (right to buy) 3.12 2014-01-02 4 M 0 3376 0 D 2018-12-12 Common Stock 3376 0 D Stock Option (right to buy) 2.59 2014-01-02 4 M 0 548 0 D 2020-04-01 Common Stock 548 0 D Stock Option (right to buy) 2.11 2014-01-02 4 M 0 1076 0 D 2020-07-01 Common Stock 1076 3710 D The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on April 2, 2013. Represents the weighted average share price of an aggregate total of 5,000 shares sold in the price range of $9.27 to $9.53 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Twenty-five percent (25%) of the shares subject to the option vested and became exercisable on April 12, 2010, and, thereafter, one thirty sixth (1/36th) of the remaining shares subject to the option vested and became exercisable in equal monthly installments over the next thirty six (36) months. One hundred percent of the shares subject to the option vested and became exercisable on April 1, 2010. One hundred percent of the shares subject to the option vested and became exercisable on July 1, 2010. /s/ William Dumencu, as Attorney-in-Fact 2014-01-02